BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15237595)

  • 21. Treatment of deep vein thrombosis with continuous intravenous infusion of LMWH in children--an alternative to subcutaneous application when needed.
    Blatný J; Fiamoli V
    Vnitr Lek; 2009 Mar; 55(3):227-32. PubMed ID: 19378852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low-molecular-weight heparin prophylaxis using dalteparin in close proximity to surgery vs warfarin in hip arthroplasty patients: a double-blind, randomized comparison. The North American Fragmin Trial Investigators.
    Hull RD; Pineo GF; Francis C; Bergqvist D; Fellenius C; Soderberg K; Holmqvist A; Mant M; Dear R; Baylis B; Mah A; Brant R
    Arch Intern Med; 2000 Jul; 160(14):2199-207. PubMed ID: 10904464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessing risk factors, presentation, and management of portomesenteric vein thrombosis after sleeve gastrectomy: a multicenter case-control study.
    Moon RC; Ghanem M; Teixeira AF; De La Cruz-Munoz N; Young MK; Domkowski P; Radecke J; Boyce SG; Rosenthal R; Menzo EL; Blanco DG; Funes DR; Jawad MA
    Surg Obes Relat Dis; 2018 Apr; 14(4):478-483. PubMed ID: 29174885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fixed-dose versus adjusted-dose low molecular weight heparin for the initial treatment of patients with deep venous thrombosis.
    Harenberg J
    Curr Opin Pulm Med; 2002 Sep; 8(5):383-8. PubMed ID: 12172440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Repeated Oral or Subcutaneous LMWH Has similar Antithrombotic Activity in a Rat Venous Thrombosis Model: Antithrombotic Activity Correlates With Heparin on Endothelium When Orally Administered.
    Hiebert LM
    J Cardiovasc Pharmacol Ther; 2017 May; 22(3):264-272. PubMed ID: 27653610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Portal and superior mesenteric vein thrombosis after splenectomy for idiopathic thrombocytopenic purpura].
    Silberstein E; Smolikov A; Levi I
    Harefuah; 1999 Mar; 136(5):364-6, 418. PubMed ID: 10914240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term efficacy and safety of once-daily enoxaparin plus warfarin for the outpatient ambulatory treatment of lower-limb deep vein thrombosis in the TROMBOTEK trial.
    Kurtoglu M; Koksoy C; Hasan E; Akcalı Y; Karabay O; Filizcan U;
    J Vasc Surg; 2010 Nov; 52(5):1262-70. PubMed ID: 20732787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Portal vein thrombosis after splenectomy for gastric malignant lymphoma.
    Fujitani K; Nishiyama A; Tsujinaka T; Hirao M; Hasuike Y; Takeda Y
    Gastric Cancer; 2003; 6(4):250-4. PubMed ID: 14716520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of portal vein thrombosis caused by blunt abdominal trauma in a patient with low protein C activity.
    Nishimura E; Misawa T; Kitamura H; Fujioka S; Akiba T; Yanaga K
    Clin J Gastroenterol; 2018 Dec; 11(6):507-513. PubMed ID: 29923164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report.
    Schiavoni M; Coluccia A
    J Med Case Rep; 2016 Oct; 10(1):276. PubMed ID: 27716428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimal dosing of subcutaneous unfractionated heparin for the treatment of deep vein thrombosis.
    Kearon C; Harrison L; Crowther M; Ginsberg JS
    Thromb Res; 2000 Mar; 97(6):395-403. PubMed ID: 10704648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anticoagulation therapy prevents portal-splenic vein thrombosis after splenectomy with gastroesophageal devascularization.
    Lai W; Lu SC; Li GY; Li CY; Wu JS; Guo QL; Wang ML; Li N
    World J Gastroenterol; 2012 Jul; 18(26):3443-50. PubMed ID: 22807615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended venous thromboembolism prophylaxis after total hip replacement: a comparison of low-molecular-weight heparin with oral anticoagulant.
    Samama CM; Vray M; Barré J; Fiessinger JN; Rosencher N; Lecompte T; Potron G; Basile J; Hull R; Desmichels D;
    Arch Intern Med; 2002 Oct; 162(19):2191-6. PubMed ID: 12390061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Portal vein thrombosis during eltrombopag treatment for immune thrombocytopenic purpura in a patient with liver cirrhosis due to hepatitis C viral infection.
    Kawano N; Hasuike S; Iwakiri H; Nakamura K; Ozono Y; Kusumoto H; Nagata K; Kikuchi I; Yoshida S; Kuriyama T; Yamashita K; Muranaka T; Kawaguchi T; Sata M; Okamura T; Ueda A; Shimoda K
    J Clin Exp Hematop; 2013; 53(2):151-5. PubMed ID: 23995112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review.
    Hull RD; Pineo GF; Stein PD; Mah AF; MacIsaac SM; Dahl OE; Ghali WA; Butcher MS; Brant RF; Bergqvist D; Hamulyák K; Francis CW; Marder VJ; Raskob GE
    Arch Intern Med; 2001 Sep; 161(16):1952-60. PubMed ID: 11525697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.
    Wang J; Chai JS; Zhang YM
    Medicine (Baltimore); 2018 Jun; 97(26):e11183. PubMed ID: 29952969
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Home therapy of venous thrombosis with long-term LMWH versus usual care: patient satisfaction and post-thrombotic syndrome.
    Hull RD; Pineo GF; Brant R; Liang J; Cook R; Solymoss S; Poon MC; Raskob G;
    Am J Med; 2009 Aug; 122(8):762-769.e3. PubMed ID: 19635277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low molecular weight heparin for deep vein thrombosis in glioma patients.
    Schmidt F; Faul C; Dichgans J; Weller M
    J Neurol; 2002 Oct; 249(10):1409-12. PubMed ID: 12382158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
    J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.